The Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Mar. 26 announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened today at $3.34 and is currently trading at $3.36. The stock showed a negative weekly performance of -11.11%.
Gilead Sciences, Inc. (NASDAQ:GILD) has defended its pricing of the drug by stating the obvious fact that it has shown a larger cure rate besides reducing massively, the side effects. They are said to be in touch with the Congress and plan to address the raised concerns. The news of the lawmakers’ letter to the company, has affected its shares, which fell by almost 5 percent. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened at $69.17, in current trading session and currently is at $70.16, by gaining 2.35%.The 52 week range of $46.53-$84.88. Company’s market capitalization is $107.98 billion.
Investment analysts at HC Wainwright initiated coverage on shares ofAriad Pharmaceuticals (NASDAQ:ARIA) in a note issued to investors on Tuesday, StockRatingsNetwork reports. The firm set a “buy” rating and a $14.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 84.21% from the company’s current price.Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is currently trading at $7.82.The EPS of the stock is -1.49. Company’s market capitalization is $1.46 billion.
Galena Biopharma Inc (NASDAQ:GALE)’s shares dropped 6.29% to $2.22. Cohen Milstein Sellers & Toll PLLC on Mar. 28 said it is conducting an investigation to determine whether Galena Biopharma and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. A class action lawsuit was filed in the U.S. District Court for the District of Oregon by another law firm on behalf of purchasers of the common stock of Galena Biopharma, Inc. (GALE) between November 6, 2013 and February 14, 2014, inclusive (the “Class Period”).Galena Biopharma Inc (NASDAQ:GALE) stock opened the session at $2.23, and now is at $2.30. The 52 week range of the GALE stock remained $1.65-$7.77 and the day range was $2.18-$2.35.
Leave a Reply